Given the abundance of connected devices, cloud-linked systems, software-driven platforms, and their ability to pose direct risks to patient safety, data integrity, and product reliability, Cybersecurity has now become more than a compliance issue. From device design to post-market support, cybersecurity is now part of every regulatory strategy and decision. Manufacturers should no longer treat cybersecurity as just an IT concern.
Cybersecurity as a compliance priority
The biggest shift in 2026 is that cybersecurity is now being treated as part of overall product/device quality. Regulators expect manufacturers to show how they approach identifying cyber risks, protecting systems, managing vulnerabilities, and maintaining security throughout the device lifecycle. Hence, device cybersecurity compliance in 2026 is now a priority for both legacy manufacturers and companies launching new digital health products.
For devices with software or connectivity features, the requirements have increased significantly. Manufacturers must provide clearer documentation, stronger testing evidence, and more structured risk controls. In practice, this means cybersecurity needs to be integrated into the device development process rather than added later as a final check.
FDA and EU expectations
The FDA’s cybersecurity approach to medical devices is pushing manufacturers to include cybersecurity evidence in premarket submissions for devices that may be exposed to cyber risk. This includes information on risk management, update planning, access controls, and vulnerability handling.
EU MDR demands stronger device documentation, traceability, and lifecycle management for cybersecurity.
For manufacturers marketing their devices in both regions, this creates a dual compliance challenge. They must align development, validation, and documentation across multiple expectations simultaneously. That makes early planning essential, especially for companies working with connected devices or software-enabled systems.
Secure design and validation
A strong cybersecurity strategy starts with secure device design. Manufacturers are expected to consider integrating cybersecurity best practices from the earliest design stage. It includes secure coding, authentication, encryption, and threat modeling of devices that connect to hospital networks, mobile apps, or cloud platforms.
Device software validation requirements now include proving functionality and ongoing security under realistic conditions, which is vital for SaMD compliance given changing risk profiles over time.
Risk and vulnerability management
Manufacturers must actively manage vulnerabilities, with plans for patching, issue communication, and corrective actions after launch.
This also connects directly to healthcare device data security. If a device stores, transmits, or processes patient data, manufacturers must show that the information is protected from unauthorized access or misuse.
Vigilare’s role
The challenge is applying cybersecurity rules to real development, documentation, and submission processes. Vigilare Biopharma supports with strategy, compliance planning, documentation, and submission readiness.
As cybersecurity becomes a larger part of medical device software regulations, companies that act quickly will have a stronger position in the market. To be prepared for 2026, treating cybersecurity as a product requirement is more sensible than treating it as a post-launch correction.